Behavior and Risk Awareness Through Video Education for Firefighters (BRAVE)

March 20, 2026 updated by: University of California, Davis

BRAVE: Behavior and Risk Awareness Through Video Education for Firefighters

The goal of this clinical trial is to evaluate the impact of short documentary-style videos to educate and inspire firefighters to take safety measures to prevent cancer incidence and mortality.

The main question it aims to answer is:

Will firefighters will have a higher perceived susceptibility to cancer, lower perceived barriers to cancer risk reduction practices, and higher perceived self-efficacy and benefit to risk reduction practices after watching the videos?

Participants will:

  • Take a Pre-Intervention survey
  • Watch one of five randomly assigned 5 minute video interventions
  • Take a Post-Intervention survey

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Interventional

Enrollment (Estimated)

1000

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • United States
    • California
      • Sacramento, California, United States, 95817
        • Recruiting
        • UC Davis Health
        • Contact:
        • Principal Investigator:
          • Shehnaz K Hussain, PhD
        • Sub-Investigator:
          • Derek Urwin, PhD
        • Sub-Investigator:
          • Laura Fejerman, PhD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Current active career California firefighter

Exclusion Criteria:

  • None

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Other
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Video 1
Participants assigned to video 1
Other: Video 1
San Francisco, brain cancer survivor
Experimental: Video 2
Participants assigned to video 2
Other: Video 2
Sacramento, colorectal/lung cancer
Experimental: Video 3
Participants assigned to video 3
Other: Video 3
LA, colorectal cancer
Experimental: Video 4
Participants assigned to video 4
Other: Video 4
LA, melanoma
Experimental: Video 5
Participants assigned to video 5
Other: Video 5
LA, breast cancer

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Post-Intervention Survey
Time Frame: Analyses will take place within 12 months of study initiation.
Questions within the domains of the health belief model (HBM) including perceived susceptibility, perceived barriers to actions, self-efficacy, perceived benefits, perceived severity, and cue to action.
Analyses will take place within 12 months of study initiation.

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of California, Davis

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

July 14, 2025

Primary Completion (Estimated)

June 1, 2026

Study Completion (Estimated)

July 1, 2026

Study Registration Dates

First Submitted

October 23, 2025

First Submitted That Met QC Criteria

March 20, 2026

First Posted (Actual)

March 27, 2026

Study Record Updates

Last Update Posted (Actual)

March 27, 2026

Last Update Submitted That Met QC Criteria

March 20, 2026

Last Verified

October 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • 2265741

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe